HUP0004647A2 - Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye - Google Patents

Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Info

Publication number
HUP0004647A2
HUP0004647A2 HU0004647A HUP0004647A HUP0004647A2 HU P0004647 A2 HUP0004647 A2 HU P0004647A2 HU 0004647 A HU0004647 A HU 0004647A HU P0004647 A HUP0004647 A HU P0004647A HU P0004647 A2 HUP0004647 A2 HU P0004647A2
Authority
HU
Hungary
Prior art keywords
eye
pharmaceutical preparations
glycosaminoglycans
treating diabetes
associated diseases
Prior art date
Application number
HU0004647A
Other languages
Hungarian (hu)
Inventor
Dieter Herr
Volker Laux
Fokko Van Der Woude
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Publication of HUP0004647A2 publication Critical patent/HUP0004647A2/en
Publication of HUP0004647A3 publication Critical patent/HUP0004647A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

InterLn=1386;>(57) A találmány glükóz-amino-glükánok diabétesszeltársult szembetegségek megelőzésére vagy kezelésére szolgálógyógyszerkészítmények előállítására való alkalmazására vonatkozik. Atalálmány ezenkívül a diabétesszel társult szembetegségek kezelésérealkalmas gyógyszerkészítményekre is vonatkozik. ÓInterLn=1386;>(57) The invention relates to the use of glucose-aminoglucans for the production of medicinal preparations for the prevention or treatment of eye diseases associated with diabetes. The invention also applies to pharmaceutical preparations suitable for the treatment of eye diseases associated with diabetes. HE

HU0004647A 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye HUP0004647A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (en) 1997-10-24 1997-10-24 Compositions for treating diabetic retinopathy
PCT/EP1998/006703 WO1999021538A2 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Publications (2)

Publication Number Publication Date
HUP0004647A2 true HUP0004647A2 (en) 2001-05-28
HUP0004647A3 HUP0004647A3 (en) 2002-01-28

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004647A HUP0004647A3 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Country Status (13)

Country Link
EP (1) EP1047434A2 (en)
JP (1) JP2001520987A (en)
KR (1) KR20010024550A (en)
CN (1) CN1277554A (en)
AU (1) AU749673B2 (en)
BR (1) BR9813098A (en)
CA (1) CA2306379A1 (en)
DE (1) DE19747195A1 (en)
HU (1) HUP0004647A3 (en)
IL (1) IL135171A0 (en)
NO (1) NO20001895L (en)
WO (1) WO1999021538A2 (en)
ZA (1) ZA989665B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (en) * 1999-07-08 2001-01-08 Bidifarm S R L USE OF PROTEOGYLICAN OLIGOSACCHARIDIC METABOLITES AS MAKER IN BIOLOGICAL FLUIDS FOR DIAGNOSIS OF BIABET AND PATHOLOGICAL COMPLICATIONS C
CN101584704B (en) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 Medicinal application of medicinal salt or derivative of heparin and low molecular heparin
WO2011122321A1 (en) * 2010-03-29 2011-10-06 国立大学法人名古屋大学 Agent for inhibiting physiological activity of heparin-binding protein
CN107137421A (en) * 2017-05-25 2017-09-08 青岛市中心医院 Dextran sulfate is preparing the application in suppressing corneal vascularization medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (en) * 1986-04-17 1988-12-23 Sanofi Sa GLYCOSAMINOGLYCANS OF THE HEPARIN OR HEPARANE-SULPHATE TYPE WITH ACTIVITY ON CELL DIVISION AND DIFFERENTIATION, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS.
JPH03500168A (en) * 1988-06-27 1991-01-17 ライナー　ローラント Use of glycosaminoglycans for the manufacture of medicines
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (en) * 1989-04-24 1990-11-20 Harvard College PROCESS FOR THE PREPARATION OF OLIGOSACARIDES OF LOW MOLECULAR WEIGHT DERIVED FROM HEPARIN OR DESPOLYMENED HEPARAN SULFATE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
WO1995005182A1 (en) * 1993-08-13 1995-02-23 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc Highly sulfated maltooligosaccharides with heparin-like properties
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
WO1999004801A1 (en) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
AU749673B2 (en) 2002-07-04
EP1047434A2 (en) 2000-11-02
BR9813098A (en) 2000-08-15
AU1335599A (en) 1999-05-17
NO20001895D0 (en) 2000-04-12
WO1999021538A3 (en) 1999-08-05
KR20010024550A (en) 2001-03-26
JP2001520987A (en) 2001-11-06
ZA989665B (en) 2000-04-25
WO1999021538A2 (en) 1999-05-06
HUP0004647A3 (en) 2002-01-28
DE19747195A1 (en) 1999-04-29
CN1277554A (en) 2000-12-20
NO20001895L (en) 2000-04-12
IL135171A0 (en) 2001-05-20
CA2306379A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
ATE241365T1 (en) PREPARATIONS CONTAINING SACCHARIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
KR960700742A (en) ATOPIC DISEASE REMEDY
HUP9902105A2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
PT87542A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL BASED ON INDOLONE DERIVATIVES FOR THE TREATMENT OF THE PARKINSON DISEASE
DE69331605D1 (en) USE OF PHENSERIN FOR THE PRODUCTION OF MEDICINES FOR TREATING COGNITIVE DISORDERS
HUP0001014A2 (en) Use of gastrointestinal lipase inhibitors
ATE235901T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPRIONATE AND GAMMA-BUTYROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
HK1029937A1 (en) Use of phanquinone for the treatment of alzheimer s disease.
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
DE69007065T2 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
MD970254A (en) Use of melatonine for treatment of patients having a medicamental dependence
HUP0004647A2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
NO990450L (en) Treatment of mental disorders
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
HUP0102116A2 (en) Paroxetine ascorbate, process for its preparation and its pharmaceutical use
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
UA22223A (en) Method for treatment of vision organ diseases
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
MX9703032A (en) New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carbo xylate of 2-[n-(1,2-benzisothiazolyl-3(2h)one-1,1-dioxide]ethyl.
MX9503363A (en) Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1.
DK8893D0 (en) MEDICAMENT FOR TREATMENT OR PREVENTION OF DISEASE